united healthcare glp-1 coverage weight loss Insurance just changed for as many as 56 million Americans when it comes to the popular medications used to promote Does Medicaid Cover GLP-1 Drugs?
Description
Top of mind for the fillfinish market on the CDMO/CMO side is Novo Holdings $16.5-billion acquisition of the CDMO, Catalent, a deal which closed last December (December 2024) and Novo Holdings subsequent sale of three fillfinish sites to Novo Nordisk for $11 billion to support Novo Nordisks blockbuster GLP-1 agonists, Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity
In the Phase 3 TRIUMPH-4 trial, participants on the 12 mg dose lost an average of 28.7% of their body weight about 71 pounds over 68 weeks
Statistical analysis Data were evaluated using Students t test or one-way analysis of variance (ANOVA) with TukeyKramers or Dunnetts post hoc tests
The New England Journal of Medicine, 10.1056/NEJMoa2511774
This drives interest in microdosing glp 1 and microdosing tirzepatide
Pulmonary Dis
